Bronchoscopy in neonates with severe bronchopulmonary dysplasia in the NICU

J Perinatol. 2019 Feb;39(2):263-268. doi: 10.1038/s41372-018-0280-y. Epub 2018 Dec 5.

Abstract

Objectives: To describe the findings, resulting changes in management, and safety profile of flexible bronchoscopy in the neonates with severe bronchopulmonary dysplasia.

Study design: This was a retrospective case series of twenty-seven neonates with severe bronchopulmonary dysplasia who underwent flexible bronchoscopy in the neonatal intensive care unit.

Results: Flexible bronchoscopy revealed airway pathology in 20/27 (74%) patients. Tracheomalacia 13/27 (48%), bronchomalacia 11/27 (40.7%), and airway edema 13/27 (48%) were the most common findings. Bronchoalveolar lavage (BAL) was performed in 17 patients. BAL culture revealed a microorganism in 12/17 (70.5%) cases. Findings from bronchoscopy resulted in change in clinical management in 17/27 (63%) patients. Common interventions included initiation of antibiotics (37%) and treatment of tracheobronchomalacia with bethanechol (22.2%), atrovent (18.5%), and PEEP titration (18.5%). Bronchoscopy was performed without significant complication in 26/27 (97%) patients.

Conclusion: Flexible bronchoscopy can be a safe and useful tool for the management of neonates with severe bronchopulmonary dysplasia.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / isolation & purification
  • Bethanechol / therapeutic use
  • Bronchoalveolar Lavage Fluid / microbiology
  • Bronchoalveolar Lavage*
  • Bronchopulmonary Dysplasia / diagnosis*
  • Bronchopulmonary Dysplasia / drug therapy
  • Bronchopulmonary Dysplasia / microbiology
  • Bronchoscopy / statistics & numerical data*
  • Female
  • Humans
  • Infant, Newborn
  • Intensive Care Units, Neonatal
  • Ipratropium / therapeutic use
  • Male
  • Philadelphia
  • Retrospective Studies
  • Tracheobronchomalacia / diagnosis*
  • Tracheobronchomalacia / drug therapy
  • Tracheobronchomalacia / microbiology

Substances

  • Anti-Bacterial Agents
  • Bethanechol
  • Ipratropium